Lifeboat Foundation

Earlier this year, we hosted the Ending Age-Related Diseases 2018 conference at the Cooper Union in New York City. This conference was designed to bring together the best in the aging research and biotech investment worlds and saw a range of industry experts sharing their insights.

Dr. Oliver Medvedik, LEAF vice president and Director of the Maurice Kanbar Center for Biomedical Engineering at the Cooper Union, chaired a panel with a focus on starting up biotech companies and dealing with the challenges inherent to launching a company in this industry.

Continue reading “Startups in the Aging Sector — Ending Age-Related Diseases 2018” »

It will be our second conference totally focussed on the science of actual human rejuvenation therapies to repair the damage of aging.

We are happy to begin introducing the speakers, starting with Dr. Jerry Shay.

Dr. Shay is the Vice Chairman of the Department of Cell Biology at The University of Texas Southwestern Medical Center in Dallas. Dr. Shay´s work on the relationships of telomeres and telomerase to aging and cancer is well recognized.

Continue reading “Undoing Aging 2019 is on the horizon” »

Today is our first Ask LEAF Anything where you can ask us questions about our work in the rejuvenation biotechnology field.

Home

Continue reading “Ask LEAF Anything” »

Invite to consolidation of efforts.

Top of Longevity and healthtech companies. AI, blockchain, digital health and mHealth are the top investment opportunities in aging world.

Is working to pioneer the full scope of everything that exists a duty? I have been contemplating aspects of that question for some years now. Here I move in the direction of articulating its nature and making the case by drawing out correlations with life extension and Immanuel Kant’s thoughts in The Metaphysical Elements of Ethics.

“IV. What are the Ends which are also Duties? They are: A. Our own perfection, B. Happiness of others.”

His notion of “categorical imperative” is that of a universally applicable, non-contradictory, absolute necessity which everyone can use pure practical reason to understand without it needing to be experienced or taught to them.

He says that “ethics may also be defined as the system of the ends of the pure practical reason.”

Continue reading “The Nature of Indefinite Life Extension in Context of Immanuel Kant’s Insights on Ethics and Duty” »

Hard as it is to believe, for the first time the life expectancy for Americans (not counting the effect of wars) has https://www.ajc.com/lifestyles/health/cdc-life-expectancy-de…279HCufnO/” target=”_blank” rel=” nofollow noopener noreferrer” data-ga-track=” ExternalLink: https://www.ajc.com/lifestyles/health/cdc-life-expectancy-de…279HCufnO/”>dropped for two consecutive years. Perhaps less hard to believe is that this is https://news.harvard.edu/gazette/story/2016/04/for-life-expe…y-matters/” target=”_blank” rel=” nofollow noopener noreferrer” data-ga-track=” ExternalLink: https://news.harvard.edu/gazette/story/2016/04/for-life-expe…y-matters/”>not true across economic levels. The richest Americans are gaining in longevity, indeed to unprecedented levels. The poor don’t have it so well, and in the U.S., this includes the shrinking middle class, who are also dying earlier. With the widening income gap, there’s a growing discrepancy between life expectancies for the rich and poor. Depending on geography, those on the lower end of the income bracket spread can expect to live 20 years less than their better-off counterparts, a shocking finding from an http://jamanetwork.com/journals/jamainternalmedicine/fullart.…2017.0918” target=”_blank” rel=” nofollow noopener noreferrer” data-ga-track=” ExternalLink: http://jamanetwork.com/journals/jamainternalmedicine/fullart.…2017.0918”>in-depth study coming out of the University of Washington.

Intervene Immune is a company focused on the age-related decline of the immune system, which is known as immunosenescence. Here, Bobby Brooke, CEO of Intervene Immune, discusses the clinical potential of regenerating the thymus as a means of reversing age-related immune system decline.

Earlier this year, we hosted the Ending Age-Related Diseases 2018 conference at the Cooper Union, New York City. This was a conference designed to bring together the best in the aging research and biotech investment worlds and saw a range of industry experts sharing their insights.

Continue reading “The Potential of Thymus Regeneration” »

New Aubrey interview.

Today we explore human longevity and life extension efforts focused on adding healthy years to a person’s lifespan, and even reversing the aging process.

Continue reading “Life Extension & Human Longevity with Dr. Aubrey de Grey on MIND & MACHINE” »

Can we delay or even reverse the aging process? The scientists at the Sinclair Lab at Harvard Medical School think so, and you can help them find out!

https://www.lifespan.io/nmn

So far the NAD+ Mouse Project by Dr. David Sinclair and his team at Harvard Medical School has raised over $43,265 for an exciting research project that is targeting the aging process. Help us reach $45,000 so we can expand the project even more.

Continue reading “Introducing the NAD+ Mouse Project” »